Nanalysis Scientific Corp. (CVE:NSCI – Get Free Report)’s stock price reached a new 52-week low during mid-day trading on Tuesday . The company traded as low as C$0.25 and last traded at C$0.27, with a volume of 351405 shares trading hands. The stock had previously closed at C$0.26.
Nanalysis Scientific Stock Performance
The company has a debt-to-equity ratio of 71.72, a quick ratio of 1.11 and a current ratio of 1.42. The company has a market capitalization of C$29.96 million, a P/E ratio of -2.17 and a beta of 0.72. The business has a 50 day moving average of C$0.35 and a 200-day moving average of C$0.39.
About Nanalysis Scientific
Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies.
Read More
- Five stocks we like better than Nanalysis Scientific
- How to buy stock: A step-by-step guide for beginners
- AppLovin Insiders Sell Shares: Stock Price Indicated Higher
- What Does a Stock Split Mean?
- Broadcom’s Stellar Outlook Sparks Hopes for a Semi Sector Rally
- Do ETFs Pay Dividends? What You Need to Know
- Salesforce’s Clear Path to $400 and Beyond
Receive News & Ratings for Nanalysis Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanalysis Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
